BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37253284)

  • 1. 7T amygdala and hippocampus subfields in volumetry-based associations with memory: A 3-year follow-up study of early Alzheimer's disease.
    Göschel L; Kurz L; Dell'Orco A; Köbe T; Körtvélyessy P; Fillmer A; Aydin S; Riemann LT; Wang H; Ittermann B; Grittner U; Flöel A
    Neuroimage Clin; 2023; 38():103439. PubMed ID: 37253284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volume changes of hippocampal and amygdala subfields in patients with mild cognitive impairment and Alzheimer's disease.
    Qu H; Ge H; Wang L; Wang W; Hu C
    Acta Neurol Belg; 2023 Aug; 123(4):1381-1393. PubMed ID: 37043115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smaller grey matter volume in the central olfactory system in mild cognitive impairment.
    Jobin B; Boller B; Frasnelli J;
    Exp Gerontol; 2023 Nov; 183():112325. PubMed ID: 37952649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural Alteration of Medial Temporal Lobe Subfield in the Amnestic Mild Cognitive Impairment Stage of Alzheimer's Disease.
    He P; Qu H; Cai M; Liu W; Gu X; Ma Q
    Neural Plast; 2022; 2022():8461235. PubMed ID: 35111220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrophy of specific amygdala subfields in subjects converting to mild cognitive impairment.
    Padulo C; Sestieri C; Punzi M; Picerni E; Chiacchiaretta P; Tullo MG; Granzotto A; Baldassarre A; Onofrj M; Ferretti A; Delli Pizzi S; Sensi SL;
    Alzheimers Dement (N Y); 2023; 9(4):e12436. PubMed ID: 38053753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.
    Kuhn E; Moulinet I; Perrotin A; La Joie R; Landeau B; Tomadesso C; Bejanin A; Sherif S; De La Sayette V; Desgranges B; Vivien D; Poisnel G; Chételat G
    Alzheimers Res Ther; 2019 Jul; 11(1):61. PubMed ID: 31286994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Arlt S; Buchert R; Spies L; Eichenlaub M; Lehmbeck JT; Jahn H
    Eur Arch Psychiatry Clin Neurosci; 2013 Jun; 263(4):335-44. PubMed ID: 22940716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Memory impairment in Amyloidβ-status Alzheimer's disease is associated with a reduction in CA1 and dentate gyrus volume: In vivo MRI at 7T.
    Hari I; Adeyemi OF; Gowland P; Bowtell R; Mougin O; Vesey P; Shah J; Mukaetova-Ladinska EB; Hosseini AA
    Neuroimage; 2024 Apr; 292():120607. PubMed ID: 38614372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Asymmetry of Hippocampus and Amygdala Defect in Subjective Cognitive Decline Among the Community Dwelling Chinese.
    Yue L; Wang T; Wang J; Li G; Wang J; Li X; Li W; Hu M; Xiao S
    Front Psychiatry; 2018; 9():226. PubMed ID: 29942265
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people.
    den Heijer T; Geerlings MI; Hoebeek FE; Hofman A; Koudstaal PJ; Breteler MM
    Arch Gen Psychiatry; 2006 Jan; 63(1):57-62. PubMed ID: 16389197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
    Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
    J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain reserve contributes to distinguishing preclinical Alzheimer's stages 1 and 2.
    Yildirim Z; Delen F; Berron D; Baumeister H; Ziegler G; Schütze H; Glanz W; Dobisch L; Peters O; Freiesleben SD; Schneider LS; Priller J; Spruth EJ; Schneider A; Fliessbach K; Wiltfang J; Schott BH; Meiberth D; Buerger K; Janowitz D; Perneczky R; Rauchmann BS; Teipel S; Kilimann I; Laske C; Munk MH; Spottke A; Roy N; Heneka M; Brosseron F; Wagner M; Roeske S; Ramirez A; Ewers M; Dechent P; Hetzer S; Scheffler K; Kleineidam L; Wolfsgruber S; Yakupov R; Schmid M; Berger M; Gurvit H; Jessen F; Duzel E
    Alzheimers Res Ther; 2023 Feb; 15(1):43. PubMed ID: 36855049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer's disease.
    Mielke MM; Okonkwo OC; Oishi K; Mori S; Tighe S; Miller MI; Ceritoglu C; Brown T; Albert M; Lyketsos CG
    Alzheimers Dement; 2012; 8(2):105-13. PubMed ID: 22404852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment.
    Kovacevic S; Rafii MS; Brewer JB;
    Alzheimer Dis Assoc Disord; 2009; 23(2):139-45. PubMed ID: 19474571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial navigation is associated with subcortical alterations and progression risk in subjective cognitive decline.
    Chen Q; Chen F; Long C; Zhu Y; Jiang Y; Zhu Z; Lu J; Zhang X; Nedelska Z; Hort J; Zhang B
    Alzheimers Res Ther; 2023 Apr; 15(1):86. PubMed ID: 37098612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impacts of baseline biomarkers on cognitive trajectories in subjective cognitive decline: the CoSCo prospective cohort study.
    Hong YJ; Ho S; Jeong JH; Park KH; Kim S; Wang MJ; Choi SH; Yang DW;
    Alzheimers Res Ther; 2023 Aug; 15(1):132. PubMed ID: 37550761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal Subfield Volumetry and 3D Surface Mapping in Subjective Cognitive Decline.
    Perrotin A; de Flores R; Lamberton F; Poisnel G; La Joie R; de la Sayette V; Mézenge F; Tomadesso C; Landeau B; Desgranges B; Chételat G
    J Alzheimers Dis; 2015 Sep; 48 Suppl 1():S141-50. PubMed ID: 26402076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do multiple system atrophy and Parkinson's disease show distinct patterns of volumetric alterations across hippocampal subfields? An exploratory study.
    Wang N; Zhang L; Yang H; Luo X; Fan G
    Eur Radiol; 2019 Sep; 29(9):4948-4956. PubMed ID: 30796577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diffeomorphometry of regional shape change rates and its relevance to cognitive deterioration in mild cognitive impairment and Alzheimer's disease.
    Tang X; Holland D; Dale AM; Younes L; Miller MI;
    Hum Brain Mapp; 2015 Jun; 36(6):2093-117. PubMed ID: 25644981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.